General Information of the Compound
Compound ID
CP0149869
Compound Name
4-dodecyl-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide
    Show/Hide
Synonyms
PHT 427
PHT-427
PHT427
    Show/Hide
Structure
Formula
C20H31N3O2S2
Molecular Weight
409.621
Canonical SMILES
CCCCCCCCCCCCc1ccc(cc1)S(=O)(=O)Nc1nncs1
    Show/Hide
InChI
InChI=1S/C20H31N3O2S2/c1-2-3-4-5-6-7-8-9-10-11-12-18-13-15-19(16-14-18)27(24,25)23-20-22-21-17-26-20/h13-17H,2-12H2,1H3,(H,22,23)
    Show/Hide
InChIKey
BYWWNRBKPCPJMG-UHFFFAOYSA-N
Physicochemical Property
logP
5.8023
Rotatable Bonds
14
Heavy Atom Count
27
Polar Areas
71.95
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44240850
SID: 85260779
ChEMBL ID
CHEMBL595583
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00845, RAC-alpha serine/threonine-protein kinase
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000448 BxPC-3 Homo sapiens (Human)  1
1
IC50 = 6300 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Kd = 40800 nM
2 Ki = 2400 nM
Clinical Information about the Compound
Drug 1 ( PHT-427 )
Drug Name PHT-427
Target(s)
Phosphoinositide dependent protein kinase-1 (PDPK1)
Inhibitor
RAC-beta serine/threonine-protein kinase (AKT2)
Inhibitor